| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 548125000 | The five-membered hetero ring consists of chalcogen, plural nitrogens, and carbon | 61 |
| 20090137816 | Process for the manufacture of diaminofurazan - This invention consists of a method for converting diaminoglyoxime to diaminofurazan that can be carried out efficiently at about atmospheric pressure without the need for high pressure containment apparatus. | 05-28-2009 |
| 20150051404 | PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR - Compositions and methods are for inducing, promoting or otherwise facilitating pain relief. More particularly, sub-normovasodilatory doses of nitric oxide donors are used in the therapeutic management of vertebrate animals including humans, for the prevention or alleviation of pain, especially neuropathic pain. In some applications of the method, nitric oxide donors can be administered by any suitable route so as to provide concentrations of NO that are about ½ to 10 | 02-19-2015 |
| 20190144401 | IMINOSYDNONE DERIVATIVES FOR CONJUGATION AND RELEASE OF COMPOUNDS OF INTEREST | 05-16-2019 |
| 548126000 | Polycyclo ring system having the five-membered hetero ring as one of the cyclos | 15 |
| 20090043103 | ORGANIC DYE USED IN DYE-SENSITIZED SOLAR CELL - An organic dye used in a dye-sensitized solar cell is described, having general formula (1): | 02-12-2009 |
| 20090156826 | METHODS FOR THE PREPARATION OF HYDROXY-SUBSTITUTED ARYL SULFAMIDE COMPOUNDS - The present invention is directed to processes for the preparation of hydroxy-substituted aryl sulfamide derivatives of the formula I or pharmaceutically acceptable salts, stereoisomers or tautomers thereof, which are monoamine reuptake inhibitors wherein the constituent variables are as defined herein. | 06-18-2009 |
| 20090299072 | Tetrasubstituted Benzenes - Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described. | 12-03-2009 |
| 20100063296 | COMPOSITION FOR TREATING INFECTIOUS DISEASES CAUSED BY HELICOBACTER - The invention relates to a compound of general formula (I) for use in a pharmaceutical composition for treating infectious diseases caused by | 03-11-2010 |
| 20100331550 | THIENOTHIOPHENE DERIVATIVES - An organic compound represented by the following general formula (I) and characterised by the conjugation of thieno[3,2-b]thiophene, thiophene and phenylene units in the conjugated compound. | 12-30-2010 |
| 20110077408 | ORGANIC DYE USED IN DYE-SENSITIZED SOLAR CELL - An organic dye used in a dye-sensitized solar cell is described, having general formula (1): | 03-31-2011 |
| 20130204007 | LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOTHIADIAZOLE COMPOUNDS - Luminescent solar concentrator (LSC) includes at least one disubstituted benzothiadiazole compound having general formula (I): | 08-08-2013 |
| 20140221663 | PROCESS FOR THE PREPARATION OF BENZOHETERO [1,3] - DIAZOLE COMPOUNDS DISUBSTITUTED WITH HETEOARYL GROUPS - Process for the preparation of a benzohetero[1,3]diazole compound disubstituted with heteroaryl groups which comprises reacting at least one benzohetero[1,3]diazole compound disubstituted with at least one heteroaryl compound. Said benzohetero[1,3]diazole compound disubstituted with heteroaryl groups can be advantageously used in the construction of luminescent solar concentrators (LSC). Furthermore, said benzohetero[1,3]diazole compound disubstituted with heteroaryl groups can be advantageously used in the construction of photovoltaic devices such as, for example, photovoltaic cells, photovoltaic modules, solar cells, solar modules, on both a rigid and flexible support. Said benzohetero[1,3]diazole compound disubstituted with heteroaryl groups can also be advantageously used as a precursor of monomeric units in the preparation of semiconductor polymers. | 08-07-2014 |
| 20140309430 | PROCESS FOR THE PREPARATION OF BENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH BENZODITHIOPHENE GROUPS - Process for the preparation of a benzoheterodiazole compound disubstituted with benzodithiophene groups which comprises reacting at least one disubstituted benzoheterodiazole compound with at least one monostannylated benzodithiophene compound. | 10-16-2014 |
| 20140309431 | DISUBSTITUTED NAPHTHOHETERODIAZOLE COMPOUNDS - Disubstituted naphthoheterodiazole compound having general formula (I): | 10-16-2014 |
| 20140371463 | BENZODITHIOPHENE DERIVATIVES AND THEIR USE AS PHOTOLUMINESCENT COMPOUNDS - Compound comprising a benzoetherodiazole group of formula (I) and at least one benzodithiophene group or a mixture of compounds comprising a benzoetherodiazole group and at least one benzodithiophene group of formulae (II) and (III). Both said compound and said mixture of compounds can be advantageously used as spectrum converters in luminescent solar concentrators (LSCs), capable, in their turn, of enhancing the performances of solar devices (i.e. devices for exploiting solar energy) such as, for example, photovoltaic cells, photoelectrolytic cells. | 12-18-2014 |
| 20150291575 | PROCESS FOR THE SYNTHESIS OF BENZOTHIADIAZOLE COMPOUNDS - The invention relates to a significantly improved process for the preparation of benzothiadxazole compounds which can be used in the production of Luminescent Solar Concentrators, (LSC). In particular, the synthesis process of the present invention is oriented towards the preparation of 4,-di-2-thienyl-2,1,3-benzo-thiadiazole. | 10-15-2015 |
| 20150344470 | PROCESS FOR THE PREPARATION OF BENZOHETERO [1, 3] DIAZOLE COMPOUNDS DISUBSTITUTED WITH HETEROARYL GROUPS - Process for the preparation of a benzohetero-[1,3]diazole compound disubstituted with brominated heteroaryl groups which comprises reacting at least one dihalogenated benzohetero—[1,3]diazole compound with at least one brominated heteroaryl compound. Said benzohetero [1,3]diazole compound disubstituted with brominated heteroaryl groups can be advantageously used in the synthesis of compounds useful in the construction of solar concentrators (LSCs—“Luminescent Solar Concentrators”). Furthermore, said benzohetero [1,3]diazole compound disubstituted with brominated heteroaryl groups can be advantageously used in the synthesis of photoactive polymers useful in the construction of photovoltaic devices (or solar devices) such as, for example, photovoltaic cells (or solar cells), photovoltaic modules (or solar modules), on both rigid or flexible supports. Furthermore, said benzohetero [1,3]diazole compound disubstituted with brominated heteroaryl groups can be advantageously used as precursor of monomeric units in the synthesis of semiconductor polymers. | 12-03-2015 |
| 20160185968 | ORGANIC DYES HAVING RIGID DONOR, PROCESS FOR PRODUCING THE SAME, AND DYE-SENSITIZED SOLAR CELL - The present invention provides organic dyes having a rigid donor and the process for producing the same. The organic dye has the structure of formula (i) or formula (ii), wherein r | 06-30-2016 |
| 20170233384 | Thienothiadiazole Compounds and Related Semiconductor Devices | 08-17-2017 |
| 548127000 | 1,2,3-thiadiazoles (including hydrogenated) | 2 |
| 20110046387 | 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF - Invention is related to novel compounds -5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles with general formula (I). The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because they inhibit Hsp90 chaperone which participate in cancer progression. This invention is also related to new intermediate compounds which are used for the synthesis of thiadiazoles of general formula (I). | 02-24-2011 |
| 20110263863 | METHOD FOR THE PREPARATION OF TIZANIDINE HYDROCHLORIDE - The invention deals with a preparation method of salts of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (tizanidine) of formula I, especially tizanidine hydrochloride, comprising preparation of a salt of tizanidine of formula I and a carboxylic acid as an intermediate, from which, after acidification with hydrogen chloride, tizanidine hydrochloride is obtained in a high yield and purity. | 10-27-2011 |
| 548128000 | 1,2,4-thiadiazoles (including hydrogenated) | 5 |
| 20100094021 | NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5YL)-DIALKYL-AMINES - The present invention discloses a novel method for preparing 3-imidazol-1-yl-[1,2,4]thiadiazole derivatives, particularly to a method of preparing 5-halo-3-imidazol-1-yl-[1,2,4]thiadiazole, more particularly (3-imidazol-1-yl-[1,2,4]thiadiazol-5-yl)-dialkyl-amines, that afford a high yield of pure product. | 04-15-2010 |
| 20100210849 | Compositions and Methods for Controlling Nematodes - Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles. | 08-19-2010 |
| 20110077409 | PROCESS FOR THE PREPARATION OF CERTAIN SUBSTITUTED SULFILIMINES - Cyano-substituted sulfilimines are produced efficiently and in high yield from the corresponding sulfides by reaction with cyanamide and hypochlorite. | 03-31-2011 |
| 548129000 | Chalcogen bonded directly to ring carbon of the thiadiazole ring | 2 |
| 20120071663 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide - The present invention relates to various processes for the preparation of N′-(4-{[3-(4-chloro-benzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide. | 03-22-2012 |
| 20150141655 | METHOD FOR THE PREPARATION OF THIADIAZOLES - The present invention relates to processes for preparing protected glyceraldehydes, such as (hydroxy)methanesulfonates. In addition, the invention relates to thiadiazoles, particularly 3-diooxolanyl-thiadiazoles. | 05-21-2015 |
| 548131000 | 1,2,4-oxadiazoles (including hydrogenated) | 17 |
| 20090054658 | Liquid Crystal Compound, Liquid Crystal Composition, Thin Film and Liquid Crystal Display - A liquid crystal compound is provided and includes a region in which an aromatic heterocyclic ring and an aromatic hydrocarbon ring linked together through a single bond, the liquid crystal compound expressing a nematic liquid crystal phase satisfying relational expression (1): | 02-26-2009 |
| 20090221834 | Synthesis of 5-Beta-Keto-1,2,4-Oxadiazoles and Conversion of 5-Beta-Keto-1,2,4 Oxadiazoles to N-Pyrazolyl Amidoximes - The disclosed invention relates to a process for preparing 5-β-keto-1,2,4-oxadiazoles of formula (I), and conversion of 5-β-keto-1,2,4-oxadiazoles (I) into N-pyrazolyl amidoximes of the formula (II) through reaction with hydrazine. The process is defined by two steps. An amidoxime, which may be prepared in situ, is condensed with a β-keto ester to form a 5-β-keto-1,2,4-oxadiazole. The 5-β-keto-1,2,4-oxadiazole is subsequently reacted with hydrazine to furnish the desired N-pyrazolyl amidoxime. The disclosed invention provides several advantages over the current state of the art for the synthesis of N-pyrazolyl amidoximes, which require the condensation of a pyrzolylamine with an actived substrate and subsequent reaction with hydroxyl amine. N-pyrazolyl amidoximes are useful synthetic intermediates, especially for the preparation of photographic developing chemicals. | 09-03-2009 |
| 20100063297 | PROCESSES FOR THE PREPARATION OF 1,2,4-OXADIAZOLE BENZOIC ACIDS - Provided herein are processes for the preparation of compounds useful for the treatment, prevention or management of diseases associated with a nonsense mutation. More specifically, provided herein are processes for the synthesis of 1,2,4-oxadiazoles. In particular, provided herein are processes useful for the preparation of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid. | 03-11-2010 |
| 20100113796 | INDOLE DERIVATIVES AS S1P1 RECEPTOR - The invention relates to compounds of formula (I) | 05-06-2010 |
| 20100121070 | METHODS FOR THE SYNTHESIS OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 05-13-2010 |
| 20100222594 | Compound, composition and thin film - A compound represented by the following formula (DII): | 09-02-2010 |
| 20100240902 | Oxadiazole Derivative, Light-Emitting Element Material, Light-Emitting Element, Light-Emitting Device, and Electronic Device - An object is to provide a novel material having a bipolar property. Another object is to provide an oxadiazole derivative having a wide band gap. Another object is to reduce power consumption of a light-emitting element, a light-emitting device, and an electronic device. The present invention provides an oxadiazole derivative represented by General Formula (1). In the formula, Ar | 09-23-2010 |
| 20110040100 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID - The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay. | 02-17-2011 |
| 20120323015 | Oxadiazole Derivative, Light-Emitting Element Material, Light-Emitting Element, Light-Emitting Device, and Electronic Device - An object is to provide a novel material having a bipolar property. Another object is to provide an oxadiazole derivative having a wide band gap. Another object is to reduce power consumption of a light-emitting element, a light-emitting device, and an electronic device. The present invention provides an oxadiazole derivative represented by General Formula (1). In the formula, Ar | 12-20-2012 |
| 20130317229 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND - An optical film comprising at least one compound represented by formula (1) is disclosed. In the formula, Y | 11-28-2013 |
| 20140039197 | PROCESSES FOR THE PREPARATION OF 3,5-DISUBSTITUTED-1,2,4-OXADIAZOLES - Provided herein are processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles and salts thereof comprising reacting a N-hydroxyamidine with an acyl chloride in a reaction mixture comprising a water-immiscible organic solvent and an aqueous base at relatively low reaction temperatures. | 02-06-2014 |
| 20150080582 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND - An optical film including at least one compound represented by formula (1) is disclosed. In the formula, Y | 03-19-2015 |
| 548132000 | Chalcogen bonded directly to ring carbon of the oxadiazole ring | 4 |
| 20100121071 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING A BENZIMIDAZOLE-7-CARBOXYLATE DERIVATIVE AND A PH CONTROL AGENT - The present invention provides a solid pharmaceutical composition containing compound (I) having an angiotensin II receptor antagonistic action and defined in the specification and a pH control agent, which composition is superior in the stability and dissolution property of compound (I). | 05-13-2010 |
| 20130317230 | Process For The Preparation Of Azilsartan Medoxomil - The present invention relates to an improved process for the preparation of azilsartan or its esters or salts thereof. Specifically, the invention provides a method for the preparation of highly pure methyl 1-[[2′-(4,5-dihydro-5-oxo-4H-1,2,4-oxa-diazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate an intermediate compound of formula (4) for azilsartan medoxomil with reduced content of desethyl impurity. The invention also involves the use of highly pure methyl 1-[[2′-(4,5-dihydro-5-oxo-4H-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate in the preparation of azilsartan or its esters or salts thereof, preferably medoxomil with reduced content of desethyl impurity. | 11-28-2013 |
| 20150011774 | PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention relates to a process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof. | 01-08-2015 |
| 20150133674 | PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR - The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders. | 05-14-2015 |
| 548133000 | Nitrogen attached directly to the oxadiazole ring by nonionic bonding | 1 |
| 20150051405 | NEW 1,2,4-OXADIAZOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF AS INTERMEDIATES IN THE PREPARATION OF INDOLIC ALKALOIDS - The present invention relates in general terms to a variously substituted 1,2,4-oxadiazol derivative, a process for their preparation, and use thereof as an intermediate in the preparation of indolic alkaloids, including phidianidine B and A. | 02-19-2015 |
| 548134000 | 1,2,5-thiadiazoles (including hydrogenated) | 2 |
| 20140275552 | Tunable Photoactive Compounds - Photoactive compositions of matter, methods for their design and synthesis, and various applications of such compositions of matter are disclosed. Such photoactive compositions may, for example, include any one or more of the following: a core moiety; a primary electron donor moiety; an electron-withdrawing moiety; and an alkyl tail. Some photoactive compositions may further include multiple additional electron donor moieties, electron-withdrawing moieties, and alkyl tails. Applications of such photoactive compositions of matter may include use in photovoltaic cells (e.g., as a p- or n-type material of the active layer of some photovoltaic cells, or as a dye to be employed in other photovoltaic cells); batteries, field-effect transistors; and light-emitting diodes. | 09-18-2014 |
| 20180022718 | UNSYMMETRICAL BENZOTHIADIAZOLE-BASED MOLECULAR COMPLEXES | 01-25-2018 |
| 548136000 | 1,3,4-thiadiazoles (including hydrogenated) | 9 |
| 20130046099 | Thiadiazole Which can be used as a Vulcanization Accelerator and Method for Obtaining Same - A thiadiazole of formula (I): | 02-21-2013 |
| 20150133675 | PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS - Compounds that inhibit PDE10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety, movement disorders and/or neurological disorders such as Parkinson's disease, Huntington's disease, Alzheimer's disease, encephalitis, phobias, epilepsy, aphasia, Bell's palsy, cerebral palsy, sleep disorders, pain, Tourette's syndrome, schizophrenia, delusional disorders, drug-induced psychosis and panic and obsessive-compulsive disorders. Pharmaceutically acceptable salts, stereoisomers, solvates and prodrugs of the compounds are also provided. Also disclosed are compositions containing a compound in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting PDE10 in a warm-blooded animal in need of the same. | 05-14-2015 |
| 20160024069 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF A PDE10 INHIBITOR - The present invention is directed to an improved process for the preparation of compounds of Formula (II) and Formula (III), which are useful in the inhibition of PDE10. In particular, the present invention is directed to an improved process for the preparation of 1-(5-(4-chloro-3,5-dimethoxyphenyl)furan-2-yl)-2-ethoxy-2-(4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl)ethanone, which is useful in the inhibition of PDE10. | 01-28-2016 |
| 548138000 | Nitrogen attached directly to the thiadiazole ring by nonionic bonding | 4 |
| 548139000 | Having -C(=X)-, wherein X is chalcogen, attached directly to the nitrogen by nonionic bonding | 4 |
| 20110004000 | Mitotic Kinesin Inhibitor - A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: | 01-06-2011 |
| 20110275827 | Mitotic Kinesin Inhibitor - A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: | 11-10-2011 |
| 20160102054 | HYDROXYINDOLE CARBOXYLIC ACID BASED INHIBITORS FOR ONCOGENIC SRC HOMOLOGY-2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2) - Inhibitors of protein tyrosine phosphatases are disclosed. The inhibitors include hydroxyindole carboxylic acids having a linker and an amine scaffold that are potent inhibitors of Src homology 2-domain containing protein tyrosine phosphatase-2. | 04-14-2016 |
| 548140000 | Additional nitrogen attached directly to the -C(=X)- group by nonionic bonding | 1 |
| 20090105482 | Urea Glucokinase Activators - The invention provides a compound of general formula (I) | 04-23-2009 |
| 548142000 | Chalcogen bonded directly to the 2- and 5- positions of the thiadiazole ring | 2 |
| 20110004001 | Process for the Preparation of Bis-DMTD - The present invention relates to a process for the preparation of bis(dimercaptothiadiazole) (or bis-DMTD), more particularly of 5,5′-dithiobis(1,3,4-thiadiazole-2-thiol), said process being carried out in a single reactor and making possible a preparation with improved yields which is more respectful of the environment. | 01-06-2011 |
| 20160016922 | FLUORINE ATOM-CONTAINING DISULFIDE COMPOUND - A disulfide compound represented by formula (1): | 01-21-2016 |
| 548143000 | 1,3,4-oxadiazoles (including hydrogenated) | 8 |
| 20120165540 | PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES - A process is described for the preparation of 3-alkylsulfinylbenzoyl derivatives of the formula (IIIa) by reaction of 3-alkylsulfinylbenzoic acids of the formula (Ib) with compounds of the formula (II) in the presence of a chlorinating agent and a base. | 06-28-2012 |
| 548144000 | Chalcogen bonded directly to ring carbon of the oxadiazole ring | 1 |
| 20110207936 | METHOD FOR PRODUCING OXADIAZOLINONE COMPOUND AND INTERMEDIATE THEREOF - A compound represented by the formula (1): | 08-25-2011 |
| 548145000 | Plural carbocyclic rings bonded directly to the oxadiazole ring | 6 |
| 20090326238 | ASYMMETRIC DENDRIMERS - Asymmetric light-emitting dendrimers having the formulae: (a) CORE-[DENDRITE1]n[DENDRITE2]m and (b) CORE-[DENDRITE]n are disclosed. | 12-31-2009 |
| 20120046472 | WHITE-EMITTING COMPOUNDS USING EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER, ORGANIC ELECTROLUMINESCENT ELEMENT AND LASER MATERIAL USING THE SAME - Provided are a white-emitting monomolecular compound using excited-state intramolecular proton transfer (ESIPT) characteristics, and an organic electroluminescence device and a laser device comprising same. The white-emitting monomolecular compound according to the present invention is prepared by covalently bonding at least two types of molecules which produce different colors and have excited-state intramolecular proton transfer (ESIPT) characteristics. The white-emitting monomolecular compound according to the present invention achieves white luminescence irrespective of the concentration thereof and of the state of the materials thereof, and therefore can be used in a variety of fields including an organic electroluminescence device and a laser device. | 02-23-2012 |
| 20120130081 | Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using the Oxadiazole Derivative - An object of one embodiment of the present invention is to provide a novel oxadiazole derivative as a substance having high excitation energy, in particular, a substance having high triplet excitation energy. One embodiment of the present invention is an oxadiazole derivative represented by General Formula (G1) below. | 05-24-2012 |
| 20140012008 | WHITE-EMITTING MONOMOLECULAR COMPOUND USING EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER, ORGANIC ELECTROLUMINESCENT ELEMENT AND LASER DEVICE USING THE SAME - Provided are a white-emitting monomolecular compound using excited-state intramolecular proton transfer (ESIPT) characteristics, and an organic electroluminescence device and a laser device comprising same. The white-emitting monomolecular compound according to the present invention is prepared by covalently bonding at least two types of molecules which produce different colors and have excited-state intramolecular proton transfer (ESIPT) characteristics. The white-emitting monomolecular compound according to the present invention achieves white luminescence irrespective of the concentration thereof and of the state of the materials thereof, and therefore can be used in a variety of fields including an organic electroluminescence device and a laser device. | 01-09-2014 |
| 20140012009 | WHITE-EMITTING MONOMOLECULAR COMPOUND USING EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER, ORGANIC ELECTROLUMINESCENT ELEMENT AND LASER DEVICE USING THE SAME - Provided are a white-emitting monomolecular compound using excited-state intramolecular proton transfer (ESIPT) characteristics, and an organic electroluminescence device and a laser device comprising same. The white-emitting monomolecular compound according to the present invention is prepared by covalently bonding at least two types of molecules which produce different colors and have excited-state intramolecular proton transfer (ESIPT) characteristics. The white-emitting monomolecular compound according to the present invention achieves white luminescence irrespective of the concentration thereof and of the state of the materials thereof, and therefore can be used in a variety of fields including an organic electroluminescence device and a laser device. | 01-09-2014 |
| 20140046073 | Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using the Oxadiazole Derivative - An object of one embodiment of the present invention is to provide a novel oxadiazole derivative as a substance having high excitation energy, in particular, a substance having high triplet excitation energy. One embodiment of the present invention is an oxadiazole derivative represented by General Formula (G1) below. | 02-13-2014 |
